Neuroscientific Corp.
United StatesFDA applicant, unverified
- Devices
- 2
What Neuroscientific Corp. makes
Neuroscientific Corp. develops software-based programs for visual contrast sensitivity testing, including the PG Consent Contrast Sensitivity Testing Program, and a system for ophthalmic diagnostics called The Venus System.
The company’s products are regulated under FDA 510(k) clearance, with devices classified as Class I and Class II. The portfolio is listed in the FDA’s 510(k) registry, and the manufacturer is based in the United States.
Catalogue
Pg Consen Contrast Sensitivity Testing Program Ref K881358
Regimes: 510(k) Registry: 510(k)The Venus System Ref K880773
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neuroscientific Corp. have in the registry?
The registry currently lists 2 devices for Neuroscientific Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neuroscientific Corp.'s devices?
Among its 2 most recently registered devices, Neuroscientific Corp. has devices listed in FDA 510(k) (2 devices).
What risk classes do Neuroscientific Corp.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Neuroscientific Corp.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neuroscientific Corp. in the registry?
The most recently registered devices listed for Neuroscientific Corp. include PG CONSEN CONTRAST SENSITIVITY TESTING PROGRAM and THE VENUS SYSTEM.